(19)
(11) EP 4 010 003 A1

(12)

(43) Date of publication:
15.06.2022 Bulletin 2022/24

(21) Application number: 20751560.2

(22) Date of filing: 06.08.2020
(51) International Patent Classification (IPC): 
A61K 38/00(2006.01)
A61K 38/18(2006.01)
 C07K 14/515(2006.01)
G01N 33/68(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 14/515; A61K 38/1891; G01N 33/574
(86) International application number:
PCT/EP2020/072179
(87) International publication number:
WO 2021/023837 (11.02.2021 Gazette 2021/06)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 07.08.2019 EP 19190563

(71) Applicants:
  • Deutsches Krebsforschungszentrum
    69120 Heidelberg (DE)
  • Universität Heidelberg
    69117 Heidelberg (DE)

(72) Inventors:
  • AUGUSTIN, Hellmut G.
    69120 Heidelberg (DE)
  • HÜBERS, Corinne
    69120 Heidelberg (DE)
  • PARI, Ashik Ahmed Abdul
    69120 Heidelberg (DE)
  • PETKOV, Martin
    69120 Heidelberg (DE)
  • FELCHT, Moritz
    69115 Heidelberg (DE)

(74) Representative: Altmann Stößel Dick Patentanwälte PartG mbB 
Theodor-Heuss-Anlage 2
68165 Mannheim
68165 Mannheim (DE)

   


(54) INHIBITION OF METASTASIS DEVELOPMENT BY NANGPTL-4